COG vs. KOO, RENX, INHC, TRLS, IQAI, FDBK, DVRG, SENS, EMIS, and CRW
Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Kooth (KOO), Renalytix (RENX), Induction Healthcare Group (INHC), Trellus Health (TRLS), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.
Cambridge Cognition vs.
Kooth (LON:KOO) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, community ranking, earnings, profitability and analyst recommendations.
Kooth has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500.
Cambridge Cognition received 95 more outperform votes than Kooth when rated by MarketBeat users. However, 90.91% of users gave Kooth an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.
65.0% of Kooth shares are owned by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are owned by institutional investors. 17.3% of Kooth shares are owned by insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.
Kooth has a net margin of 7.89% compared to Cambridge Cognition's net margin of -10.07%. Kooth's return on equity of 23.83% beat Cambridge Cognition's return on equity.
Kooth presently has a consensus target price of GBX 585, suggesting a potential upside of 228.65%. Given Kooth's stronger consensus rating and higher probable upside, equities research analysts plainly believe Kooth is more favorable than Cambridge Cognition.
In the previous week, Kooth had 1 more articles in the media than Cambridge Cognition. MarketBeat recorded 2 mentions for Kooth and 1 mentions for Cambridge Cognition. Kooth's average media sentiment score of 1.13 beat Cambridge Cognition's score of 0.54 indicating that Kooth is being referred to more favorably in the media.
Summary
Kooth beats Cambridge Cognition on 14 of the 18 factors compared between the two stocks.
Get Cambridge Cognition News Delivered to You Automatically
Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Cambridge Cognition Competitors List
Related Companies and Tools
This page (LON:COG) was last updated on 1/22/2025 by MarketBeat.com Staff